Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population
Open Access
- 8 November 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 7 (1), 206
- https://doi.org/10.1186/1471-2407-7-206
Abstract
The distribution and the potential gene-gene and gene-environment interaction of selected metabolic genetic polymorphisms was investigated in relation to gastric cancer risk in an Italian population.Keywords
This publication has 33 references indexed in Scilit:
- CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: a meta-analysis of the literatureCarcinogenesis: Integrative Cancer Research, 2007
- No Association between Polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the Risk of Gastric Adenocarcinoma in the European Prospective Investigation into Cancer and NutritionCancer Epidemiology, Biomarkers & Prevention, 2006
- Sulfotransferase 1A1 polymorphism and gastric cancer risk: a pilot case-control studyCancer Letters, 2005
- Calculating measures of biological interactionEuropean Journal of Epidemiology, 2005
- Gastric cancer: New genetic developmentsJournal of Surgical Oncology, 2005
- Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysisCancer Letters, 2005
- Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophaguscclm, 2005
- Relationship between genetic polymorphisms of drug-metabolizing enzymes ( CYP1A1 , CYP2E1 , GSTM1 , and NAT2 ), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancerThe Esophagus, 2004
- Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysemaThe Lancet, 1997
- Restriction fragment length polymorphism of the human CYP 2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancerPharmacogenetics, 1994